Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study

NCT03988231 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding was not received.

Conditions

Venous Thromboembolism
Bleeding as Surgical Complication (Treatment)
Deep Venous Thrombosis
Pulmonary Embolism

Interventions

DRUG: Receipt of enoxaparin
DRUG: Placebo

Sponsor

University of Utah

Collaborators

[object Object]